Applied DNA Sciences, Inc. | Finanzwire

Basculer en Français

11018	Companies
241409	Keywords
169918	Articles
129955	Press releases

Headlines Articles Press releases Applied DNA Sciences, Inc.

Home
Companies
Applied DNA Sciences, Inc.

PRESS RELEASE

published on 02/08/2024 at 22:05, 2 years 7 months ago

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually

Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
PRESS RELEASE

published on 02/05/2024 at 19:00, 2 years 7 months ago

Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies

Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
PRESS RELEASE

published on 02/02/2024 at 22:15, 2 years 7 months ago

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services

Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
PRESS RELEASE

published on 01/31/2024 at 14:00, 2 years 7 months ago

Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent

Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
PRESS RELEASE

published on 12/14/2023 at 14:00, 2 years 9 months ago

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE

published on 12/07/2023 at 22:05, 2 years 9 months ago

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE

published on 12/05/2023 at 14:30, 2 years 9 months ago

Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results

Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE

published on 11/28/2023 at 14:30, 2 years 9 months ago

Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE

published on 11/16/2023 at 14:30, 2 years 10 months ago

Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE

published on 11/09/2023 at 15:15, 2 years 10 months ago

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

Accesswire

Published on 09/17/2026 at 15:55, 5 hours 47 minutes ago

Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 6 hours 17 minutes ago

AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 6 hours 42 minutes ago

Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 6 hours 42 minutes ago

ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 6 hours 52 minutes ago

Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 19:00, 2 hours 42 minutes ago

Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 2 hours 43 minutes ago

EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 3 hours 17 minutes ago

Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 3 hours 32 minutes ago

A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 3 hours 56 minutes ago

RBI categorically denies the allegations of short-seller report

Les Echos

Published on 09/17/2026 at 17:40, 4 hours 2 minutes ago

Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 20:46, 1 day ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 1 day 3 hours ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 1 day 3 hours ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 14 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

View all LES ECHOS COMFI WIRE